CN Stock MarketDetailed Quotes
688253 Innovita Biological Technology
- 40.86
- -0.21-0.51%
Market Closed Dec 12 15:00 CST
5.58BMarket Cap16.79P/E (TTM)
41.37High40.63Low23.44KlotVolume41.09Open41.07Pre Close95.87MTurnover3.41%Turnover Ratio32.05P/E (Static)136.46MShares52.6952wk High2.73P/B2.81BFloat Cap23.2152wk Low49.28Limit Up68.81MShs Float52.69Historical High32.86Limit Down1.80%Amplitude18.72Historical Low0.40Dividend TTM40.90Avg Price15.86KlotAsk0.98%Div YieldTTM100Lot Size7.26KlotBid
Innovita Biological Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 87.05%520.82M | 88.33%421.06M | 109.36%281.61M | 7.03%478.02M | -10.34%278.43M | -10.49%223.58M | 93.55%134.51M | 36.62%446.62M | 17.46%310.53M | 15.06%249.79M |
| Operating revenue | 87.05%520.82M | 88.33%421.06M | 109.36%281.61M | 7.03%478.02M | -10.34%278.43M | -10.49%223.58M | 93.55%134.51M | 36.62%446.62M | 17.46%310.53M | 15.06%249.79M |
| Total operating cost | 43.16%247.2M | 42.95%177.7M | 26.94%99.56M | -11.34%262.27M | -2.75%172.68M | -9.66%124.31M | 47.68%78.43M | 46.27%295.83M | 20.31%177.55M | 24.78%137.6M |
| Operating cost | 25.46%99.2M | 18.99%77.42M | 0.68%46.33M | -33.74%114.81M | -30.20%79.07M | -26.61%65.07M | 92.03%46.02M | 127.17%173.28M | 89.44%113.29M | 91.48%88.66M |
| Operating tax surcharges | 41.14%3.08M | 42.50%2.32M | 51.12%1.53M | -64.16%3.21M | -65.95%2.18M | -53.13%1.63M | 39.11%1.01M | 204.74%8.95M | 174.76%6.41M | 85.00%3.48M |
| Operating expense | 70.22%55.55M | 84.07%38.16M | 87.14%20.31M | 15.72%58.18M | -0.48%32.63M | 11.57%20.73M | 20.16%10.85M | 5.09%50.28M | -1.70%32.79M | -19.81%18.58M |
| Administration expense | -1.23%32.31M | -7.72%19.33M | 10.68%10.82M | 0.88%40.92M | 20.32%32.71M | 26.81%20.95M | 37.05%9.77M | 12.30%40.56M | -3.34%27.19M | -15.69%16.52M |
| Financial expense | 52.84%-3.93M | 44.32%-3.75M | -280.11%-1.41M | 83.89%-7.96M | 83.55%-8.32M | 71.67%-6.73M | -42.92%784.5K | -720.50%-49.42M | -4,697.91%-50.6M | -824.06%-23.74M |
| -Interest expense (Financial expense) | -43.25%91.28K | -41.49%65.53K | -37.86%36.19K | -51.25%199.59K | -30.91%160.86K | -33.63%112K | -38.28%58.24K | 205.82%409.45K | 103.10%232.83K | 80.77%168.73K |
| -Interest Income (Financial expense) | 27.04%-4.73M | 32.38%-3.35M | 50.85%-1.34M | -5.41%-7.64M | -36.00%-6.48M | -287.41%-4.95M | -367.20%-2.72M | -259.68%-7.25M | -166.77%-4.76M | -8.14%-1.28M |
| Research and development | 77.28%60.99M | 95.07%44.21M | 120.09%21.98M | -26.42%53.11M | -29.03%34.4M | -33.56%22.66M | -8.17%9.99M | 132.00%72.18M | 112.01%48.47M | 112.52%34.11M |
| Credit Impairment Loss | -835.55%-13.06M | -1,066.15%-19.02M | -5,927.37%-19.01M | 32.51%-4.52M | 60.85%-1.4M | 55.50%-1.63M | 260.62%326.15K | -2,026.49%-6.69M | -10,309.50%-3.57M | -11,307.40%-3.66M |
| Asset Impairment Loss | 92.21%-2.04M | 91.51%-2.04M | 89.02%-378.93K | -6,695.09%-45.24M | -5,618.72%-26.23M | -9,305.58%-24.07M | -2,748.09%-3.45M | 30.65%-665.79K | 13.81%-458.74K | -144.08%-255.92K |
| Other net revenue | ||||||||||
| Fair value change income | 2.06%4.68M | 5.54%4.48M | 148.15%4.86M | 311.13%9.15M | 1,565.53%4.59M | 2,123.03%4.25M | 579.85%1.96M | 151.22%2.23M | -53.62%275.31K | -56.32%191K |
| Invest income | 50.17%18.12M | 80.16%11.59M | 26.62%4.85M | 248.36%16.93M | 1,401.24%12.07M | 305.30%6.43M | 730.62%3.83M | 208.66%4.86M | -46.58%803.89K | 25.12%1.59M |
| -Including: Investment income associates | ---- | 42.73%-936.32K | ---1.06M | -0.24%-1.06M | ---- | ---1.63M | ---- | ---1.06M | ---- | ---- |
| Asset deal income | --221.68 | ---806.39 | --22.09 | -82.92%2.19K | ---- | ---- | ---- | --12.83K | --12.83K | --12.83K |
| Other revenue | -74.23%1.81M | -79.59%1.32M | -74.65%869.75K | -54.72%7.98M | -49.28%7.02M | -50.69%6.47M | -72.91%3.43M | 32.69%17.63M | 423.51%13.83M | 428.63%13.12M |
| Operating profit | 178.13%283.13M | 164.23%239.69M | 178.66%173.25M | 18.97%200.05M | -29.25%101.8M | -26.36%90.71M | 109.05%62.17M | 20.30%168.16M | 18.87%143.88M | 11.04%123.18M |
| Add:Non operating Income | 129.36%203.36K | 375.08%214.83K | 712.38%254.59K | 97.36%290.19K | -4.78%88.66K | -47.82%45.22K | 29.05%31.34K | 189.73%147.04K | 414.87%93.11K | 564.07%86.66K |
| Less:Non operating expense | -91.64%139.9K | -95.06%62.18K | 142,003.66%239.29K | -47.84%1.98M | -32.45%1.67M | -48.03%1.26M | -99.96%168.39 | 86.80%3.8M | 140.70%2.48M | 135.47%2.42M |
| Total profit | 182.59%283.19M | 167.99%239.84M | 178.54%173.26M | 20.58%198.36M | -29.18%100.21M | -25.94%89.5M | 112.11%62.2M | 19.38%164.51M | 17.89%141.5M | 9.94%120.84M |
| Less:Income tax cost | 182.18%38.58M | 177.86%33.58M | 224.14%27.18M | 76.60%24.41M | -0.97%13.67M | -1.52%12.09M | 182.14%8.38M | -21.66%13.82M | -9.28%13.81M | -15.31%12.27M |
| Net profit | 182.65%244.61M | 166.45%206.26M | 171.44%146.09M | 15.44%173.95M | -32.23%86.54M | -28.70%77.41M | 104.21%53.82M | 25.40%150.68M | 21.83%127.69M | 13.78%108.57M |
| Net profit from continuing operation | 182.65%244.61M | 166.45%206.26M | 171.44%146.09M | 15.44%173.95M | -32.23%86.54M | -28.70%77.41M | 104.21%53.82M | 25.40%150.68M | 21.83%127.69M | 13.78%108.57M |
| Less:Minority Profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.64%-335.53 |
| Net profit of parent company owners | 182.65%244.61M | 166.45%206.26M | 171.44%146.09M | 15.44%173.95M | -32.23%86.54M | -28.70%77.41M | 104.21%53.82M | 25.31%150.68M | 21.73%127.69M | 13.67%108.57M |
| Earning per share | ||||||||||
| Basic earning per share | 181.25%1.8 | 166.67%1.52 | 167.50%1.07 | 3.23%1.28 | -35.35%0.64 | -46.23%0.57 | 53.85%0.4 | 5.08%1.24 | -3.88%0.99 | 12.77%1.06 |
| Diluted earning per share | 181.25%1.8 | 164.91%1.51 | 167.50%1.07 | 3.23%1.28 | -35.35%0.64 | -46.23%0.57 | 53.85%0.4 | 5.08%1.24 | -3.88%0.99 | 12.77%1.06 |
| Other composite income | -367.59%-3.49M | -300.37%-2.89M | 63.23K | -1.02M | 1.3M | 1.44M | ||||
| Other composite income of parent company owners | -367.59%-3.49M | -300.37%-2.89M | --63.23K | ---1.02M | --1.3M | --1.44M | ---- | ---- | ---- | ---- |
| Total composite income | 174.48%241.11M | 157.92%203.38M | 171.56%146.15M | 14.76%172.92M | -31.21%87.84M | -27.37%78.85M | 104.21%53.82M | 25.40%150.68M | 21.83%127.69M | 13.78%108.57M |
| Total composite income of parent company owners | 174.48%241.11M | 157.92%203.38M | 171.56%146.15M | 14.76%172.92M | -31.21%87.84M | -27.37%78.85M | 104.21%53.82M | 25.31%150.68M | 21.73%127.69M | 13.67%108.57M |
| Total composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.64%-335.53 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
